Recombinant multi-species Myocilin/MYOC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Myocilin/MYOC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
MYOC encodes the protein myocilin, which is believed to have a role in cytoskeletal function. MYOC is expressed in many occular tissues, including the trabecular meshwork, and was revealed to be the trabecular meshwork glucocorticoid-inducible response protein (TIGR). The trabecular meshwork is a specialized eye tissue essential in regulating intraocular pressure, and mutations in MYOC have been identified as the cause of hereditary juvenile-onset open-angle glaucoma. [provided by RefSeq, Jul 2008]
The Alternative Names of target: GLC1A,GPOA,JOAG,JOAG1,MYOC,Myoc,Myocilin,Myocilin 55 kDa subunit,TIGR,Tigr,Trabecular meshwork-induced glucocorticoid response protein

Target products collectionGo to Myocilin/MYOC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1117-Ag-1/ GM-Tg-hg-SE1117-Ag-2 Human Myocilin/MYOC protein Human
GM-Tg-rg-SE1117-Ag-1/ GM-Tg-rg-SE1117-Ag-2 Rat Myocilin/MYOC protein Rat
GM-Tg-mg-SE1117-Ag-1/ GM-Tg-mg-SE1117-Ag-2 Mouse Myocilin/MYOC protein Mouse
GM-Tg-cynog-SE1117-Ag-1/ GM-Tg-cynog-SE1117-Ag-2 Cynomolgus/Rhesus macaque Myocilin/MYOC protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1117-Ag-1/ GM-Tg-felg-SE1117-Ag-2 Feline Myocilin/MYOC protein Feline
GM-Tg-cang-SE1117-Ag-1/ GM-Tg-cang-SE1117-Ag-2 Canine Myocilin/MYOC protein Canine
GM-Tg-bovg-SE1117-Ag-1/ GM-Tg-bovg-SE1117-Ag-2 Bovine Myocilin/MYOC protein Bovine
GM-Tg-equg-SE1117-Ag-1/ GM-Tg-equg-SE1117-Ag-2 Equine Myocilin/MYOC protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1117-Ag-1/ GM-Tg-hg-SE1117-Ag-2; GM-Tg-rg-SE1117-Ag-1/ GM-Tg-rg-SE1117-Ag-2;
GM-Tg-mg-SE1117-Ag-1/ GM-Tg-mg-SE1117-Ag-2; GM-Tg-cynog-SE1117-Ag-1/ GM-Tg-cynog-SE1117-Ag-2;
GM-Tg-felg-SE1117-Ag-1/ GM-Tg-felg-SE1117-Ag-2; GM-Tg-cang-SE1117-Ag-1/ GM-Tg-cang-SE1117-Ag-2;
GM-Tg-bovg-SE1117-Ag-1/ GM-Tg-bovg-SE1117-Ag-2; GM-Tg-equg-SE1117-Ag-1/ GM-Tg-equg-SE1117-Ag-2
Products Name Myocilin/MYOC protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Myocilin/MYOC
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Myocilin/MYOC protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.